Neudle.com: multiple sclerosis progressive

Differential
(Click to cross reference)

abdominal reflex, absent

abducens nerve paralysis

abscess, intracerebral

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adenylate kinase 5 autoantibodies

adrenoleukodystrophy

advances in neurology

adverse drug reaction

alemtuzumab

Alexanders disease

Alexanders disease, adult onset

algorithm

alkylating agents

alternating rapid movement, impaired

amphiphysin antibodies

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, diagnosis of

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

amyotrophic lateral sclerosis, prognosis

amyotrophic lateral sclerosis, treatment of

amyotrophic lateral sclerosis, work up

ANA

analgesic

aneurysm

aneurysm, cavernous sinus

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiography, cerebral, beaded vessels

angiography, cerebral, false negative

angiography, cerebral, negative

angiography, spinal

ankle edema

anterior interosseous neuropathy

anti JC virus antibodies

anti MAG antibodies

antibiotics

antibodies to measles

arterial dissection, aorta

arteriovenous malformation

arteriovenous malformation, cerebral

atlanto axial dislocation, congenital

auditory evoked brainstem potentials

autoantibodies

autoimmune cerebellar ataxia

autoimmune disease

autonomic dysfunction

Barkhof MR criteria for MS

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

bone marrow suppression

bone marrow transplantation

Borrelia burgdorferi infection

brachial neuritis

brachial plexus neuropathy

brain biopsy

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

brainstem, lesion of

brucellosis, nervous system involvement with

carbon monoxide poisoning

CAT scan, demyelinating disease

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, serial

cauda equina, enhancement

cavernous sinus

cavernous sinus, expansion

cavernous sinus, lesion of

cavernous sinus, syndrome

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar pontine angle tumor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, gold sol.curve of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrospinal fluid, proteincytologic dissociation

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, mimics

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, women

cerebrovascular disease

cervical rib

cervical spine

cervical spine injury

cervical spondylosis

cervical spondylosis, differential diagnosis of

cervical spondylosis, misdiagnosis

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

clinodactyly

collagen vascular disease

collapsin response mediator protein 5 IgG

coma

comorbidities

complications

compression neuropathy

congenital deformities

congenital infection, CNS

congenital infection, viral

congestive heart failure

contactin associated protein like 2 antibodies

contractures, joint

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cranial nerve enhancement

cranial neuropathy

cranial neuropathy, multiple

C-reactive protein, elevated

creatine phosphokinase(CPK)elevated

CREST syndrome

critical care unit

crying, pathologic

cryptococcal meningitis

cyclophosphamide

cyclosporine

cystinuria

cytomegalovirus infection

degenerative diseases of CNS

dementia, frontotemporal

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dermatitis

dermatomyositis

developmental retardation

diabetes mellitus

diagnostic criteria

diaphragmatic paralysis

diarrhea

diarrhea, bloody

diencephalon

differential diagnosis

diffuse axonal injury

digits, abnormal

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

distal muscle atrophy

drug abuse

drug holiday

drug induced neurologic disorders

dystrophic calcification

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

encephalitis, autoimmune

encephalitis, bornavirus

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, recurrent

encephalitis, viral

encephalocele

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

endemic area

endovascular therapy

enterovirus

entrapment neuropathy

epidemiology of neurology

evidence-based research

evoked potentials

exostosis

experimental allergic encephalitis

eye, pain in

face, numbness of

facial nerve palsy

facial nerve palsy, recurrent

facial pain

facial weakness

facial weakness, bilateral

fistula, arterio-venous

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

fourth ventricle, floor

fundus, abnormality of

funduscopic exam

F-wave response

gadolinium

gag reflex, depressed

gait disorder

gait, spastic

gait, waddling

gamma amino butyric acid

gamma amino butyric acid-mimetic drug

gammaglobulin therapy, intravenous

genu of corpus callosum

geographic location

glioblastoma multiforme(astrocytoma Gr.III)

glioma

gliomatosis cerebri

glutamic acid decarboxylase, antibody

GM1 ganglioside antibodies

granulomatosis with polyangiitis

granulomatous disease

gray matter

Guillain Barre syndrome

hearing loss, bilateral

hearing loss, sudden, bilateral

hearing loss, sudden, unilateral

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus

herpes virus infection

herpes zoster

heterochromia iridis

hiccoughs

highly active antiretroviral therapy

hip pain

hippocampal atrophy

hippocampus

hippocampus, hyperintense

histochemistry

histochemistry of muscle

HLA

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

homosexual

Horner's syndrome

Horner's syndrome, etiologies of

hospice

human herpesvirus 6

human immunodeficiency virus type 1

human T-lymphotropic virus type I(HTLV-I)

hypertensive encephalopathy

hypertrophic intracranial pachymeningitis

hypertrophic spinal pachymeningitis

hypogonadism

hypopigmentation of skin

iatrogenic neurologic disorders

imbalance

immune checkpoint inhibitors

immune complexes

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

incidence

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, eosinophilic intranuclear

inclusion bodies, intranuclear

inclusion body myositis

infantile tremor syndrome

infection

infliximab

intellectual deficit

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intermittent positive pressure breathing

internet

intracerebral hemorrhage

intrathecal antispasticity drugs

intrauterine infection

intrauterine infection, viral

intrauterine infection, viral of CNS

Jakob-Creutzfeldt disease

laminectomy, cervical

laughing, pathologic

leg weakness, bilateral

lenticular nucleus, lesion of, bilateral

lesions too numerous to count

leucine rich glioma inactivated 1 antibodies

leukemia

leukodystrophy

leukoencephalitis

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

levamisole

level of consciousness, decreased

Lewy body disease, diffuse

Lhermitte's sign

life sustaining treatment

limbic encephalitis

lipoma of CNS

lipoprotein receptor-related protein 4

lymphadenopathy, hilar

lymphocytic meningoradiculitis

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

maculopathy

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

malignancy screen

malignancy, occult

Marburg's disease

Marchiafava-Bignami disease

median neuropathy

medical-legal aspects of neurology

medulla oblongata

medulla oblongata, lesion of

Melkersson's syndrome

memory, defect of recent

memory, impairment of

meningeal biopsy

meningeal enhancement

mental status, abnormal

merosin

mesial temporal lobe

metachromatic leukodystrophy

methotrexate

microangiopathy, brain

microangiopathy, retina

microdactyly

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

mitochondrial disease

mitoxantrone

mobility

mobility aids

monoclonal antibodies

monoclonal gammopathy

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

morphine

mortality

motor neuron disease

motor neuron disease, juvenile form

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, field strength, high

MRI, FLAIR

MRI, flow void, blood

MRI, functional

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, lesion burden

MRI, magnetization transfer sequence

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, T1 weighted high signal foci

multiple sclerosis, acute

multiple sclerosis, aggressive

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, late-onset

multiple sclerosis, lesion location

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, worsening

multiple system atrophy

muscle atrophy, progressive

muscle weakness, proximal

muscular dystrophy

muscular dystrophy, Becker, carrier

muscular dystrophy, cardiovascular changes with

muscular dystrophy, central nervous system abnormality

muscular dystrophy, congenital

muscular dystrophy, Duchenne, carrier

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, ocular

myasthenia gravis, paraneoplastic

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

myelin

myelitis

myelitis, longitudinal

myelitis, transverse

myeloma, osteosclerotic

myelomalacia

myelopathy

myelopathy, ascending

myelopathy, chronic progressive

myelopathy, ischemic-due to trauma or spondylosis

myositis ossificans, progressive

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve biopsy

nerve conduction studies

nerve conduction studies, motor

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, incurable

neurologic disease, multifocal

neurologic disease, multiple

neurologic examination

neurologic practice

neurologic signs

neurologic symptoms

neuromuscular blockade

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, painful

neuropathy, paraneoplastic

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, vasculitic, systemic

neuroprotective agents

night sweats

NMDA antagonists

numbness, generalized

nystagmus

nystagmus, vertical

ocrelizumab

old age, neurology of

onconeural antibodies

ophthalmoplegia

ophthalmoplegia, painful

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

optic chiasm

optic glioma

optic nerve

optic nerve, compression of

optic nerve, enhancement

optic nerve, enlarged

optic nerve, lesion of

optic nerve, neoplasm of

optic neuritis

optic neuritis, bilateral

otitis, neurologic complications with

oxygen therapy

pachymeningitis, cranial

paralysis, acute areflexic

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

paraparesis, spastic, tropical

paraplegia

paraproteinemia

paraspinal muscle

paratrigeminal syndrome

paresthesias

paresthesias, hands

Parkinson disease

Parkinson disease, treatment of

pathology

patient information and support

periarteritis nodosa

perineum, numbness of

periodic paralysis

periodic paralysis, thyrotoxic

peripheral nerve, lesion of

personality change

phenylketonuria

phenylketonuria, adult onset

phrenic nerve pacemaker

physical therapy

physician assisted suicide

placebo

plasmacytoma

plasmapheresis

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

POEMS syndrome

poliomyelitis

poliomyelitis-like illness

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior inferior cerebellar artery syndrome

posterior interosseous neuropathy

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive hemifacial atrophy

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive spinal muscular atrophy

progressive supranuclear palsy

prosopagnosia

pseudobulbar palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychomotor retardation

ptosis

ptosis, bilateral

pulmonary edema

pulmonary infiltrates

pupil

pupil, abnormality in neurologic disorders

pyramidal tract dysfunction

quadriparesis

quadriparesis, acute

quadriparesis, progressive

quadriplegia

quality of life

race

radiation therapy, CNS treatment and complications with

radicular pain

radiculitis

Rankin score

rapidly fatal neurologic illness

rapidly progressing neurologic illness

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

reticular activating system

retinal artery occlusion

retinal branch artery occlusion

retinal infarction

retinopathy

retrovirus

reversible neurologic disorder

risk-benefit assessment

rituximab

Rosenthal fibers

rubella encephalitis, progressive

scleroderma, neurologic involvement with

sedimentation rate, elevated

seizure

sensorineural hearing loss

sensory loss

serologic testing

serologic testing of cerebrospinal fluid

seronegative

seropositive

short thumb

shunt procedure, ventricular

shunt procedure, ventricular-complications of

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

slow virus infection of CNS

small vessel disease

solitary scerlosis

spasticity

spasticity, treatment of

spinal cord, cervical

spinal cord, compression of

spinal cord, injury of

spinal cord, injury, management of

spinal cord, lesion of

spinal cord, vascular malformation of

spinal pachymeningitis

spinal stenosis

spinal stenosis, cervical canal

spirochete infection

splenomegaly

spondylosis

spongy degeneration of brain

statin therapy

stem cell tourism

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stiff legs

stiff man syndrome

strokelike episodes

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

Susac's syndrome

sweet taste

symmetric brain lesions

symptomatic

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal artery, biopsy

temporal lobe, lesion

temporal lobe, lesion, bilateral

tenderness

thalamus, lesion of

thalamus, lesion of-bilateral

Thies's sign

thoracic outlet syndromes

tone, muscle, increased

tongue, atrophy

tongue, fasciculations of

tongue, impaired movements of

tonsillectomy

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient ischemic attack

transient neurologic deficit

trauma

treatment of neurologic disorder

tremor

trigeminal neuropathy

trigeminal neuropathy, sensory

tuberculosis

tumefactive lesion

tumor necrosis factor

tumor necrosis factor inhibitor

ulcerative colitis

ulnar neuropathy

upward deviation of eyes

vaccination, neurologic complications with

vaccine

valium

vascular endothelial growth factor

vasculitides

vasculopathy

vertebral-basilar insufficiency

vertigo

viral infection

viral infection, CNS

viral infection, reactivation

viremia

viruria

virus, slow

vision loss, sequential

vision, blurred

visual evoked response

visual loss

visual loss, progressive

visual loss, slow

visual loss, slow-unilateral

visual loss, sudden

Waldenstrom's macroglobulinemia

walking frame

walking, difficulty with

water channel antibodies

weakness, generalized

weakness, progressive

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

X-linked bulbospinal neuronopathy

Showing articles 50 to 100 of 5397 << Previous Next >>

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
Arch Neurol 66:601-609, Seewann,A.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Cortical Lesions in Primary Progressive Multiple Sclerosis: A 2-Year Longitudinal MR Study
Neurol 72:1330-1336, Calabrese,M.,et al, 2009

Combining Beta Interferon and Atorvastatin May Increase Disease Activity in Multiple Sclerosis
Neurol 71:1390-1395,1386, Birnbaum,G.,et al, 2008

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Curable Cause of Paraplegia: Spinal Dural Arteriovenous Fistulae
Stroke 39:2756-2759, Aghakhani,N.,et al, 2008

Neurologic Manifestations of Localized Scleroderma: A Case Report and Literature Review
Neurol 71:1538-1545, Kister,I.,et al, 2008

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006

Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder
Brain 129:3150-3164, Jellema, K., et al, 2006

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004

Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002

Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

The Prevalence of Sjogren Syndrome in Patients with Primary Progressive Multiple Sclerosis
Neurol 57:1359-1363,1357, de Seze,J.,et al, 2001

Phenylketonuria Presenting in Adulthood as Progressive Spastic Paraparesis With Dementia
JNNP 71:795-797, Kasim,S.,et al, 2001

The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001

Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001

Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000

A 44-Year-Old Woman with Difficulty Walking
JAMA 284:2632-2639, Iezzoni,L.I., 2000

The Clinical Spectrum of Anti-GAD Antibody-Positive Patients with Stiff-Person Syndrome
Neurol 55:1531-1535, Dalakas,M.C.,et al, 2000

Showing articles 50 to 100 of 5397 << Previous Next >>